Table 4.
The development of individual MS components after 5 years
Abdominal obesity | Hyperglycemia | Hypertension | Low HDL-C | High TG | |
---|---|---|---|---|---|
Whole cohort | 317/2350 (13.5%) |
578/2350 (24.6%) | 489/2350 (20.8%) | 228/2350 (9.7%) |
673/2350 (28.6%) |
Subjects without any MS components at baseline | 77/1171 (6.6%) |
175/1171 (14.9%) |
125/1171 (10.7%) |
77/1171 (6.6%) |
155/1171 (13.2%) |
MS, metabolic syndrome; HDL-C, high density lipoprotein cholesterol; TG, triglyceride